Ibrutinib is an effective treatment for B-cell prolymphocytic leukaemia

Max J. Gordon, Phil Raess, Kathleen Young, Stephen Spurgeon, Alexey Danilov

Research output: Contribution to journalArticle

4 Citations (Scopus)
Original languageEnglish (US)
JournalBritish Journal of Haematology
DOIs
StateAccepted/In press - 2016

Fingerprint

B-Cell Prolymphocytic Leukemia
Prolymphocytic Leukemia
Cytogenetics
PCI 32765

Keywords

  • Cytogenetics
  • Ibrutinib
  • Prolymphocytic leukaemia

ASJC Scopus subject areas

  • Hematology

Cite this

@article{ad0568c3bfa74180bebc27d3fa6dfd91,
title = "Ibrutinib is an effective treatment for B-cell prolymphocytic leukaemia",
keywords = "Cytogenetics, Ibrutinib, Prolymphocytic leukaemia",
author = "Gordon, {Max J.} and Phil Raess and Kathleen Young and Stephen Spurgeon and Alexey Danilov",
year = "2016",
doi = "10.1111/bjh.14224",
language = "English (US)",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Ibrutinib is an effective treatment for B-cell prolymphocytic leukaemia

AU - Gordon, Max J.

AU - Raess, Phil

AU - Young, Kathleen

AU - Spurgeon, Stephen

AU - Danilov, Alexey

PY - 2016

Y1 - 2016

KW - Cytogenetics

KW - Ibrutinib

KW - Prolymphocytic leukaemia

UR - http://www.scopus.com/inward/record.url?scp=84994075785&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994075785&partnerID=8YFLogxK

U2 - 10.1111/bjh.14224

DO - 10.1111/bjh.14224

M3 - Article

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

ER -